A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI
Clinical trial NCT01634555 · COMPLETED
Trial details
- NCT number
- NCT01634555
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-08-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.